Stock Price
151.96
Daily Change
-2.11 -1.37%
Monthly
-6.91%
Yearly
-26.28%
Q1 Forecast
152.81

Date Reference Time Actual Consensus Previous
2026-04-30 FY2026Q4 AM 0.83 0.48
2026-04-20 FY2026Q1 1.68 1.66
2025-10-18 FY2025Q3 AM 1.13 1.69 1.6
2025-08-30 FY2025Q2 AM 0.73 1.40 1.23
2025-05-05 FY2025Q1 1.66 0.68 0.65



Peers Price Chg Day Year Date
Cspc Pharmaceutical 8.20 -0.29 -3.42% 66.67% Mar/26
Avita Medical 1.12 -0.01 -0.44% -60.14% Mar/26
Sh Fosun Pharma 25.26 -0.10 -0.39% 1.08% Mar/26
Jiangsu Hengrui 51.72 -2.38 -4.40% 6.88% Mar/26
Zhangzhou Pientzehuang Pharmaceutical 151.96 -2.11 -1.37% -26.28% Mar/26
Kangmei Pharma 1.74 -0.03 -1.69% -19.07% Mar/26
WuXi AppTec 94.47 0.45 0.48% 38.93% Mar/26
Akebia Therapeutics 1.40 0.04 2.94% -27.08% Mar/25
Tectonic Therapeutic 31.06 0.99 3.29% 63.39% Mar/25
Ionis Pharmaceuticals 72.69 3.01 4.32% 130.84% Mar/25

Indexes Price Day Year Date
SHANGHAI 50 2825 -34.32 -1.20% 4.99% Mar/26

Zhangzhou Pientzehuang Pharmaceutical Co Ltd traded at 151.96 this Thursday March 26th, decreasing 2.11 or 1.37 percent since the previous trading session. Looking back, over the last four weeks, Zhangzhou Pientzehuang Pharmaceutical lost 6.91 percent. Over the last 12 months, its price fell by 26.28 percent. Looking ahead, we forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd to be priced at 152.81 by the end of this quarter and at 142.86 in one year, according to Trading Economics global macro models projections and analysts expectations.

Zhangzhou Pientzehuang Pharmaceutical Co Ltd is a China-based company mainly engaged in drug production and sales. The Company is also engaged in the production and sales of cosmetics and daily chemical products and the circulation of medicine. The Company''s core products are PianZi Huang series products, including PianZi Huang, PianZi Huang capsule, compound PianZi Huang buccal tablets, compound PianZi Huang ointment, compound PianZi Huang hemorrhoids ointment and others, covering many fields such as liver disease medication, cold medication, dermatology medication. The Company''s products are sold to domestic and overseas markets.